Posted on

Red Light Holland and Mistercap LLC Partnership Update

Red Light Holland and Mistercap LLC Partnership Update

Clarification and additional information pertaining to the June 30th, 2022 Press Release regarding Red Light Holland and the MISTERCAP mushroom wellness brand.

Toronto, Ontario–(Newsfile Corp. – July 18, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of functional (e.g. shiitake, lion’s mane) mushroom home grow kits in North America, and a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to provide this clarification and update with additional information regarding its partnership with Mistercap LLC.

The partnership created by Red Light Holland and Mistercap LLC for the new Mushrooms wellness brand called MISTERCAP, will initially launch with a functional mushroom home grow kit, allowing customers to grow their own legal mushrooms in the comfort of their own homes, expected to be sold in Q4 of 2022. From there, the companies intend to expand to other legal, functional and innovative mushroom products, as well as a line of apparel and accessories, to be made available across the EU and North America in early 2023. Further, Mistercap LLC will be receiving marketing advisory services from the multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa for the new MISTERCAP brand, who will leverage his social media presence to promote legal mushroom products.

The MISTERCAP brand, in conjunction with Red Light Holland, is also committed to creating educational and responsible use messaging in relation to the use of any products made available by the brand. Red Light Holland and Mistercap LLC will share further details on the MISTERCAP products, team, and vision in the weeks to come. MISTERCAP products will be intended to help promote a healthy lifestyle. No MISTERCAP products are intended to treat or cure any medical conditions and are in no event a substitute for professional medical care. No statements made by Red Light Holland, Mistercap LLC or Wiz Khalifa have been evaluated by the United States Food and Drug Administration or any other similar body of another jurisdiction, and are in no event a substitute for professional medical care. Red Light Holland, Mistercap LLC and Wiz Khalifa encourage all consumers to speak with their doctors and professional medical advisors for any solutions that may be appropriate for each person individually.

About MISTERCAP

MISTERCAP is a mushroom wellness brand founded in 2022 to create innovative functional mushroom wellness products and isaffiliated with multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa, who provides marketing advisory services to the company. More information will be made available in the coming weeks on MISTERCAP.COM and INSTAGRAM.COM/MISTERCAP

Transaction Details

As has previously been disclosed, in connection with launching the MISTERCAP brand, Red Light Holland and Mistercap, LLC have entered into an intellectual property licensing agreement (the “IP Licensing Agreement“). Pursuant to the terms of the IP Licensing Agreement, Mistercap, LLC shall exclusively license certain intellectual property held by Mistercap, LLC to Red Light Holland to develop, cultivate, process, package, distribute and sell mushroom and/or truffle-related products under the MISTERCAP brands. The initial term of the IP Licensing Agreement shall be for three years and shall be automatically renewable for one-year successive terms upon Red Light Holland continuing to hit certain benchmark sales targets. As partial consideration for the license, Mistercap, LLC will be paid (i) C$250,000 in cash and (ii) C$1,000,000, which is to be satisfied through the issuance of common shares in the capital of Red Light Holland (the “Common Shares“) at a price of $0.075 per Common Share. The Common Shares will be subject to a four month and one day hold period pursuant to the polices of the Canadian Securities Exchange (“CSE“) and applicable securities laws. In addition, Mistercap, LLC will: (x) receive monthly royalty payments paid over the term of the IP Licensing Agreement, calculated based on the sale of products developed pursuant to the partnership and (y) be paid a monthly marketing fee. Additional payments are due in the event future markets are available to sell in pursuant to the terms of the IP Licensing Agreement. The Company has budgeted C$1,000,000 per year to fulfill royalty fees, marketing expenses and additional payment obligations owed to Mistercap, LLC pursuant to the terms of the IP Licensing Agreement. The Company plans on reallocating a majority of the $1,800,000 marketing budget outlined under the heading “Use of Proceeds and Milestones” in the Company’s management discussion and analysis for the nine months ended December 31, 2021 towards growing the MISTERCAP brand.

About Red Light Holland Corp.

The company is an Ontario-based corporation that specializes in the mushroom industry, and specifically home grow kits for functional natural mushrooms, while positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

Mistercap, LLC

The Lede Company / Chris Iacullo <Chris.Iacullo@ledecompany.com>
The Lede Company / Hannah Haines <Hannah. Haines@ledecompany.com>
The Lede Company / Sami Brensilber <Samantha.Brensilber@ledecompany.com>

Website: www.mistercap.com

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the plans and goals of the Company and MISTERCAP, including the launch of the MISTERCAP website and associated merchandise; the success of the MISTERCAP brand; future product offerings of the Company under the MISTERCAP brand; the timelines and markets associated with launching products under the MISTERCAP brand; the future marketing and advertising campaigns of the Company and MISTERCAP, including how the Company’s marketing budget will be utilized; additional payment obligations owing to MISTERCAP pursuant to the terms of the IP Licensing Agreement; the focus of the Company and MISTERCAP brand; the ongoing consideration payable under the IP Licensing Agreement; the renewability of the IP Licensing Agreement; and future changes in legislation and the regulations surrounding, among other things, the ability to sell the Company’s products in new markets.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; the Company and MISTERCAP fulfilling its future plans and goals, including the launch of the MISTERCAP website and associated merchandise; the MISTERCAP brand and future product offerings of the Company under the MISTERCAP brand succeeding; the Company launching products under the MISTERCAP brand upon the timelines and in the markets disclosed herein; the Company, MISTERCAP launching future marketing and advertising campaigns, including the Company’s marketing budget being utilized as outlined herein; additional payments being paid to MISTERCAP pursuant to the terms of the IP Licensing Agreement; the Company’s revenues will continue to grow; the Company and MISTERCAP fulfilling their respective obligations under the IP Licensing Agreement; the Company hitting certain benchmark sales under the IP Licensing Agreement; the term of the IP Licensing Agreement continuing to renew; additional jurisdictions permitting sales of the brand’s products in the future; and future changes in legislation and the regulations not impacting the Company’s ability to fulfil its plans and goals, including the ability to sell the Company’s products in new markets.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth, expansion, production, sales and commercialization of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the industry, including the global regulatory landscape and enforcement related to the brand’s products; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the industry; risk that the Company’s products will be unsafe for personal consumption and/or not provide their anticipated benefits; risk that there may not be continued demand for the Company’s products and/or demand will plateau; risk that the Company and MISTERCAP may be unable to fulfill their future plans and goals, including the launch of the MISTERCAP website and associated merchandise; risk that the MISTERCAP brand and/or the product offered under the brand will be unsuccessful and will not sell; risk that the Company will be unable to offer product under the MISTERCAP brand; risks that the Company will be unable to meet the timelines and/or sell in the markets outlined herein associated with launching products under the MISTERCAP brand or at all; risks surrounding future marketing and advertising campaigns of the Company and MISTERCAP, including how the Company’s marketing budget will be utilized; risks around the quantum owing under the additional payment obligations owed to MISTERCAP pursuant to the terms of the IP Licensing Agreement; risk that the Company, alongside MISTERCAP, will be unable to increase revenues; risk that the Company and MISTERCAP will be unable to fulfill their respective obligations under the IP Licensing Agreement; risk that the Company will be unable to hit certain benchmark sales under the IP Licensing Agreement; risk that the term of the IP Licensing Agreement won’t be renewed following the initial term; risks surrounding additional jurisdictions not permitting sales of the brand’s products in the future; risk of future changes to regulations surrounding the brand’s products and/or to the Company’s business which may hinder the ability of the Company to attain its goals and/or pursue its plans and/or sell its products in additional markets; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR atwww.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland to Head Sponsor Psy-Fi Festival in The Netherlands from September 14-18, 2022, One Of The Largest Psy-Trance Festivals In Europe

Red Light Holland to Head Sponsor Psy-Fi Festival in The Netherlands from September 14-18, 2022, One Of The Largest Psy-Trance Festivals In Europe

  • Red Light Holland will be the exclusive provider of natural Psilocybin products at the festival estimated to host approximately 15,000 people
  • Red Light Holland will proudly sell their iMicrodose and Maka products and feature their technology Wisdom VR and Wisdom Truffle at Psy-Fi
  • Red Light Holland will provide educational workshops to promote the responsible use of Psychedelics

Toronto, Ontario–(Newsfile Corp. – July 13, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce its sponsorship of Psy-Fi festival, one of the largest international festivals in the Netherlands which attracts thousands of visitors each year. Psy-Fi offers a large variety of music, arts, and space for personal growth.

As a lead sponsor, Red Light Holland will be the exclusive provider of Psilocybin Truffles for the festival, including featuring the Company’s iMicrodose and Maka Brands. As part of the offerings to the festival, Red Light Holland will deploy its suite of technology products including the VR experience, Wisdom, which explains how Psychedelics influence the brain (https://store.steampowered.com/app/1561720/Wisdom/). Red Light Holland will also showcase their innovative meditation device, designed by world famous structural designer Karim Rashid, The Wisdom Truffle (www.WisdomTruffle.com). Red Light Holland will further provide preparation and integration workshops to promote the responsible use of Psychedelics. These efforts will be led by Jeff Hamburg, Red Light Holland’s therapist and expert psychedelic guide and Sarah Hashkes Red Light Holland’s Chief Innovation and Technology Officer. The Psy-Fi festival will take place in The Netherlands, September 14th-18th, 2022.

“This is a huge opportunity for us to connect to a worldwide audience that shares the same values of increasing legal access to naturally occuring Psilocybin. We are thrilled to collaborate with such a well-known and respected festival that is known for its safety-first practices as well as its care about the environment,” said Todd Shapiro, CEO, and Director of Red Light Holland. “We’re excited to show the world our Rec & Tech approach with our branded psilocybin products, technology devices and our educational and responsible use messaging aiming to bring people a lot of joy and connection.”

“Psy-Fi ‘Guardians of the Gala’ is set up to be one of the bigger Psy-Trance festivals in Europe. Our team is very pleased to be able to be such a big part of a beautiful and fun festival,” said Hans Derix, Red Light Holland’s President and Dutch Native. “We will be displaying and selling our Maka and iMicrodose products via our wholly owned company SR-Wholesale to thousands of people affordably and responsibly. And our intention is to have a big Brand presence. You should come down to our amazing country in September and check it out,” added Derix.

To learn more about the festival or purchase tickets go to: https://www.psy-fi.nl/.

Red Light Holland releases Data on Psychedelic Concert

Red Light Holland releases a report with data analysis around the success of the Company’s Psychedelic concert event on April 16th, 2022. During this event participants chose to consume between 1 to 8 grams of Red Light Holland’s premium Psilocybin truffles after an intake discussion with therapist and expert psychedelic guide Jeff Hamburg. After the event participants were sent a survey and the facilitators were interviewed for the report. A small number of participants replied, but with positive results.

  • 91.7% of the attendees in the survey reported they would be interested in attending another event, 75% reported they enjoyed the music more than usual
  • 41.7% reported they felt connected to the group in a meaningful way
  • 33.3% reported lasting benefits beyond the event itself

The long-term benefits included the release of negative emotions and a lasting “Uplifted mood”. Some participants also gained insight that helped them in their personal or professional life. No significant negative effects were reported or observed.

The report with detailed statistical analysis conducted by statistician Yoav Blonder, has been sent to Oregon Health Authority representatives and members of the Washington Psilocybin service workgroup, as well as other government officials around the world Red Light Holland is connected with, to help promote regulations and best practices for group psilocybin services.

While there is no statistical significance due to the small sample size Red Light Holland sees the potential of these events in increasing affordable and equitable accessibility, especially for newcomers to the psychedelic community, as newcomers might be more interested in trying psychedelics in a safe environment supervised by experts.

The Company can not make medical claims regarding the use of psilocybin.

To read the full report: https://redlight.co/wp-content/uploads/2022/07/Psychedelic-Concert-Report.pdf.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website:www.RedLight.co

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: the details of the planned psy-fi festival September 14-18, 2022; the ability to sell Maka and iMicrodose products at the Psy-Fi Festival; comments with respect to the data discovered assisting Red Light if and when the final regulations in Oregon are approved; details with respect to Measure 109; Red Light’s plans to conduct further research in the Netherlands, statements regarding Red Light’s involvement in Psy-fi festival; the intended outcomes and effects of Measure 109; statements regarding the implementation of Measure 109 by the Oregon Health Authority; details regarding the sponsorship organzied by Red Light Holland including the ability to be the lead supplier of Red Light products at Psy-Fi Festival; Red Light’s expectations of obtaining the consent of concert-goers and participants to collect and analyze data on best practices on using psychedelics and the company’s products; Red Light’s plans to be the exclusive provider of Psilocybin Truffles for the festival and the company’s ability to deploy its suite of technology products including the VR experience, Wisdom and the company’s mediation device, The Wisdom Truffle; Red Light Holland; Red Light Holland premium psilocybin truffles being available for concert goers at the event; that sponsoring the event will enable Red Light to advocate for a program that helps a wide range of Oregonians; that the data provided from the past group microdosing event will illustrate a working model to help the Oregon Psilocybin Advisory Board and the Oregon Health Authority to refine psilocybin regulations as well as help form the Washington’s Psilocybin Wellness Workgroup; the belief that the report on microdosing services can benefit people or the inability for the report to represent medical claims; the company can not make medical claims; that the report and small sample size of the data will influence Oregon, Washington State Authorities to help with regulations; that the report is a small sample size and therefore is just a small sample of participants and not used for the purposes of medical advice.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: Red Light’s ability to carry the sponsorship and be the exclusive provider of Psilocybin Truffles for the festival; Red Light Holland setting up and deploying its suite of technology products including the VR experience, Wisdom and their innovative meditation device, The Wisdom Truffle. Red Light Holland will further provide preparation and integration workshops to promote the responsible use of Psychedelics discussed in this news release, or at all; the ability of the past group microdosing event and the subsequent report to yield the expected information to assist Red Light with legalization efforts described in this new release, or at all; the report will not affect the Measure 109 being implemented; Red Light Holland’s ability to continue as a going concern; the continued commercial viability and growth in popularity of psilocybin products; continued approval of Red Light Holland by the relevant governmental and/or regulatory authorities; the continued growth of Red Light Holland; details regarding the event organized by Psy-Fi Festival organizers, including the live performances; Red Light’s continued expectations of obtaining the consent of facilitators, concert organizers and participants including concert goers to provide psilocybin truffles; Red Light Holland premium products of psilocybin truffles being available for concert-goers at the event; that the report on the group microdosing event will illustrate a working model to help the Oregon Psilocybin Advisory Board and the Oregon Health Authority to refine psilocybin regulations as well as help form the Washington’s Psilocybin Wellness Workgroup; the inability of the report to be received, read by, or acknowledged by Oregon Authorities, Washington State Authorities and other Government agencies and officials around the world.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of Red Light to carry the sponsorship of Psy-Fi festival on the terms and timelines described in this news release; the potential inability of Red Light Holland to continue as a going concern; the risks associated with the psychedelics industry in general; increased competition in the recreational and medical psilocybin markets; the potential future unviability of the psychedelics industry; public opinion and perception of the psychedelics industry; incorrect assessment of the value and potential benefits of expansion plans and various transactions; risks associated with potential governmental and/or regulatory action with respect to the psychedelics industry; changes in general economic, business and political conditions, including changes in the financial and stock markets; and risks related to infectious diseases, including the impacts of the COVID-19 pandemic; the event not proceeding as detailed and no longer organized by Psy-Fi festival organizers, including the cancellation of all the performances at the festival and/or the planned and concurrently ability to offer of the company’s products during the event Sept 14-18 2022; the risk that Covid-19 could result in the canceling of the Psy-Fi festival, Red Light’s inability to sell products and promote best practices on usage of the company’s products; Red Light’s inability to sell products and promote best practices on usage of the company’s products at the Psy-Fi festival; Red Light Holland premium iMicrodose and Maka psilocybin truffles being unavailable for concert goers; that the report on the group microdosing event will not illustrate a working model to help the Oregon Psilocybin Advisory Board and the Oregon Health Authority to refine psilocybin regulations as well as not helping form the Washington’s Psilocybin Wellness Workgroup; the belief that the statistics provided on the microdosing event can become integrated into people’s daily life not come into fruition; the report does not represent a medical diagnosis; the report represents a very small sample size and does not represent any statistical significance.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect Red Light Holland’s expectations as of the date hereof and are subject to change thereafter. Red Light Holland undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity and Equity in Alignment with Measure 109 Regulations

Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity and Equity in Alignment with Measure 109 Regulations

● Red Light Holland launches: ‘Red Light. Set. Go!’ program to work with exceptional local Oregonians from diverse backgrounds who wish to enter the legal psilocybin service market.

● Shunji Smith, Japanese American avid mushroom grower, teacher, and small business owner from Eugene, Oregon joins the program.

● Red Light Holland and Halo Collective mutually dissolve Red Light Oregon, Inc.

Toronto, Ontario–(Newsfile Corp. – June 28, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce its updated plan regarding aiming to enter the legal psilocybin service market that will be created by the adoption of Measure 109 in the state of Oregon (“Measure 109“).

While some of the regulations in Oregon are still unclear at this time, Measure 109 intends to promote diversity and provide a head start to local Oregonians, which prompted Red Light to create the ‘Red Light. Set. Go!’ program (the “Program“) – a unique program aimed at working with exceptional Oregonians from diverse backgrounds who wish to enter the legal psilocybin service market. The Program will provide selected candidates with expert advice and funding to help them attempt to enter the legal psilocybin service market.

Shunji Smith, a Japanese American avid mushroom grower, teacher, and small business owner from Eugene, Oregon, is the first to team up with the Company under the Program.

“I’ve been a big believer in Red Light’s mission since I first heard of them and I’m very grateful to join this Program,” exclaimed Mr. Smith. “It’s a big dream of mine to enter the Oregon Psilocybin services market on the manufacturing side and with Red Light’s support, I believe together we can make a big impact,” added Mr. Smith.

“We noticed a big gap between Measure 109’s intentions and what we are seeing on the ground when it comes to promoting diversity and equity as the regulations are complex and entering the market requires initial capital that most individuals wishing to enter do not have access to” said Todd Shapiro, Chief Executive Officer and a Director of Red Light Holland. “Therefore, we established this Program to further align our vision with the intention of Measure 109 while seeking to provide value to our shareholders. With this Program, we will continue to grow our Mycelium network. Shunji has a combination of unique expertise and a deep passion for the promise of psilocybin services so we are very excited to work with him,” added Mr. Shapiro.

Measure 109 will make psilocybin services available to Oregonians 21 years and older without a need for medical diagnosis. The service must include a required prep-session, psilocybin session in a licensed facility supervised by a licensed facilitator and a possibility of an integration session. On December 31, 2022, the Oregon Health Authority will prescribe forms and regulations necessary for the exact implementation. To follow the current state of regulations in Oregon check out OHA website: https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Oregon-Psilocybin-Services.aspx

Dissolution of Red Light Oregon, Inc.

Further to the Company’s joint press with Halo Collective Inc. (“Halo“) released date April 27, 2021, the Company wishes to announce that Halo and the Company have agreed to mutually dissolve Red Light Oregon, Inc.

“We wish Halo well, but after monitoring Oregon’s developments of Measure 109 very closely and having conversations with an Oregonian Senator, Measure 109 committee members, legal counsel and our direct Red Light team on the ground – we genuinely believe that our true alignment and best step forward is with our newly formed ‘Red Light. Set. Go!’ initiative. We are excited to work with Shunji and look forward to more advancements in Oregon,” said Sarah Hashkes, Red Light Holland Chief Technology and Innovation officer.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the future plans and goals of the Company; the success of the Program; future participants and guidelines of the Program; Red Light Oregon, Inc. being dissolved; the adoption of Measure 109 and future regulations surrounding psilocybin and the Company; the Company providing funding and expertise to Program participants; the continued growth of the Mycelium network; and future changes in legislation, including Measure 109 and the regulations surrounding psilocybin.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; continued demand for the Company’s microdosing products; the success of the Program, including the Company adding future participants to the Program; Red Light Oregon, Inc. being dissolved; the adoption of Measure 109 and future regulations surrounding psilocybin and the Company not changing such that the Program will be unable to continue; the Company providing funding and expertise to Program participants; the continued growth of the Mycelium network; and future changes in legislation, including Measure 109 and the regulations surrounding psilocybin not impacting the Company’s ability to fulfil its plans and goals.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; risks surrounding the success of the Program and the ability of the Company to gain future Program participants; risk that Red Light Oregon, Inc. will not be dissolved; risk that Measure 109 with not be adopted and/or future changes to regulations surrounding psilocybin and/or the Company’s business may hinder the ability of the Company to attain its goals and/or pursue its plans; risk that the Company will be unable to fund and/or provide expertise to Program participants; risks that the Company’s Mycelium network will no longer grow and/or plateau; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland Closes Acquisition of 100 Acres of Farmland in Ontario, Canada Expanding its Mushroom Farms Division in North America

Red Light Holland Closes Acquisition of 100 Acres of Farmland in Ontario, Canada Expanding its Mushroom Farms Division in North America

  • Purchase of 100 acres farmland for $1.85 Million
  • Through experienced partners, Red Light’s Farm Division plan on growing mushroom production with projected additional 65,000 sq. feet of “Innovative and Unique” Mushroom production facilities
  • Mike Medeiros (AEM Partner, Carleton Mushroom Farm co-owner and President of Mushrooms Canada) excited to “start building an advanced world class Mushroom Farm” with Red Light as Canadian mushroom production continues to increase as more domestic and export market opportunities open up

Toronto, Ontario–(Newsfile Corp. – June 20, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light” or the “Company“), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce that it has closed on their previously announced acquisition of 100 acres of farmland located at in the township of Cavan-Monaghan in Peterborough, Ontario (the “Farm“) for $1.85 million, paid in cash from treasury (the “Acquisition“).

STRATEGIC HIGHLIGHTS

The Company intends to work with Acadian Exotic Mushrooms Ltd. (“AEM Farms“), an operational gourmet mushroom production facility in New Brunswick, Ontario, which is majority owned by Red Light (as previously disclosed on September 7, 2021), and co-owned by leading Canadian mushroom farming groups/individuals Holburne Mushroom Farm and Mike and Fernando Medeiros, who co-own Carleton Mushroom Farms, to develop the Farm into approximately 65,000 sq. feet of two Mushroom production facilities (to be called “AEM Ontario“). The Acquisition will enable the Company to dramatically expand its farm division (“Red Light Farms“), which already includes Happy Caps Gourmet Mushroom Farm in Halifax, Nova Scotia, AEM Farms in New Brunswick, Ontario and Red Light’s truffle farm in Horst, The Netherlands. The Company has already started engineered plans on AEM Ontario and expects to start construction in the Summer of 2022 as planning and productive conversations with the township of Cavan-Monaghan continue.

“We are extremely confident at Red Light because of how prudent we have been at running our psychedelic business, preserving cash at a time when most of our peers are straining to attract new capital. Red Light Holland on the other hand, has a significant cash position as we are clearly focused on increasing revenues while having a strategic and aligned plan to grow, in order to weather difficult markets and harder economic times,” said Todd Shapiro, CEO and Director of Red Light. “As I’ve said before, we have a clear direction and don’t mind being patient as we aim on growing now and in the future. I’m very excited for this summer as we are also aiming to make some more significant announcements. We look forward to updating the market when AEM Ontario commences operations and in the meantime, we are pleased to add a strong asset on the books – a beautiful piece of Ontario farmland with a stunning farm house for future employees,” added Mr. Shapiro.

“I maintain that Todd has a clear and confident vision to accelerate growth in a proven mushroom industry that fuels the expansion of the close cousin, psilocybin,” said Bruce Linton, Chair of Red Light’s advisory board. “As Todd continues to innovate, lead and push the limits, like no other company in the recreational psychedelic sector, he also grows partnerships with industry leaders. It’s a great strategy. I’m proud to be a part of this clever, creative and fun team who are focused on continued growth,” added Mr. Linton.

“The purchase of 100 acres of farmland will provide AEM Farms with another great opportunity, which we feel will be very successful,” said Mike Medeiros, co-owner of Carleton Mushroom Farms and President of Mushrooms Canada. “As planning continues and the permit process begins, we look forward to starting to build an advanced world class mushroom farm – so innovative and unique in fact, that only a few like it exist in the world,” added Mr. Medeiros.

About Mike and Fernando Medeiros and Holburne Mushroom Farm

Carleton Mushroom Farms was founded in 1984 by Mike and Fernando’s parents and remains a family run business. Mike and Fernando took over day to day operations in 2005. In recent years growing capacity has tripled, and yields have steadily increased to 12 million pounds per year. Carleton Mushroom Farms implements cutting edge technologies from around the world as part of their growing practices. Website: https://www.carletonmushroom.com/.

Holburne Mushroom Farm is a local family owned and operated business that specializes in growing fresh, organic Shiitake and Oyster Mushrooms since 2005. Production of Organic Shiitake and Oyster Mushrooms has steadily increased to current yield of 1.3 million pounds per year. Proudly, the largest fresh, Organic Shiitake Mushroom growers in Canada.

About Red Light Holland

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.redlight.co

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, AEM Farms, AEM Ontario or Red Light Farms or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: Red Light completing the development of Red Light Farms on the terms and within the timelines set out in this news release; Red Light receiving requisite approvals for the development of Red Light Farms; the anticipated effects of the Acquisition on the business and operations of Red Light, including Red Light Farms and AEM Ontario increasing Red Lights’ revenues and profit; providing Red Light with potential new revenue generation; enhancing shareholder value of Red Light; the anticipated operating abilities of AEM Ontario; the anticipated start of the project to start in the summer of 2022; the commencement of operations at AEM Ontario; the potential that the Red Light Farms and AEM Ontario facilities being converted to support Canadian psychedelic operations; and expectations for other economic, business and/or competitive factors.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; supply chain and construction delays due to uncertain economic times; the potential inability to find trades, skilled workers and contractors due to worker shortages, risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Stability Test Under a Health Canada Approved cGMP Laboratory

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Stability Test Under a Health Canada Approved cGMP Laboratory

  • Red Light Holland’s iMicrodose packs containing Psilocybe Tampanensis Truffles, produced in the Netherlands, tested at CCrest Laboratories, under a Health Canada approved Psilocybin license.
  • Red Light Holland and CCrest Laboratories continue to demonstrate their strong commitment to the highest standards for naturally occurring Psilocybin products.
  • Red Light Holland has an established alliance with CCrest Laboratories Inc. in partnership with Shaman Pharma Corp., who have been listed by Health Canada as a Psilocybin supplier to the Special Access Program.

Toronto, Ontario–(Newsfile Corp. – June 6, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that it has received a report from the first stability test conducted on the company’s Psilocybin Truffles sold in the Netherlands. This report was focused on optimizing shelf life and the long-term quality of the product. The report confirmed Red Light Holland’s iMicrodose packs containing tampanensis truffles have a psilocybin equivalent content to be 1.23 mg/gram one week after opening the truffles. This baseline measurement will help in future studies to research Psilocybin content over longer periods of time which will be crucial in any potential clinical use of naturally occurring Psilocybin. The report also confirmed the importance of keeping fresh truffles refrigerated after opening them, which Red Light Holland currently mentions on all iMicrodose packs sold.

The testing performed by CCrest Laboratories in Montreal, Canada demonstrates the Company’s commitment to standardization, research and development in hopes of being able to advocate to Health Canada that their farm grown truffles could be an option of naturally occurring psychedelics for those patients in need under the new Special Access Program (“SAP”). CCrest Laboratories, Red Light Holland’s partner, has been listed as a provider of Psilocybin via SAP, if and when requests are made by health practitioners and all Government approvals are met.

“Step by step we continue to move towards a standardized consistent dose of naturally occurring psilocybin truffles that can potentially benefit all legal markets,” said Todd Shapiro, CEO and Director of Red Light Holland. “As far as we know our truffles are the first to go through such rigorous testing which shows our commitment to increasing scientific knowledge of these natural products and having the best products on the market. The legal market in the Netherlands and the market opening in Oregon next year are focused on naturally occurring Psilocybin which our market research shows many people prefer over synthetics – so it’s exciting that Red Light Holland with the help of Shaman Pharma is working towards giving people what they want. We hope other governments around the world will follow to legalize the responsible use of a substance that has been used by many civilizations for thousands of years.”

“Working with natural Psilocybin is exciting and we continue to learn and progress our methods of discovery,” said Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories.

Red Light Holland’s partner, CCrest Laboratories will continue to perform stability tests and R&D towards creating a standardized consistent dose from naturally occurring psilocybin truffles.

Red Light Holland continues to establish itself as a leader in the recreational sector and push for legal, responsible, and safe access to natural psychedelic truffles/mushrooms while Scarlette Lillie Science and Innovation pursues research and development, technology, and applied science.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

About Shaman Pharma Corp.

Shaman Pharma is a federally registered Canadian corporation with the mission to power outstanding psychedelic life science innovation. Accelerating time-to-market through its portfolio of assets, Shaman launches and consolidates revenue-driven pharma-biotech life sciences ventures focused on supplying psychedelic drugs & novel active ingredients.

Forward-Looking Statements

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of Red Light Holland. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements include, but are not limited to: statements with respect to the Company creating a standardized consistent dose from naturally occurring psychoactive truffles; statements with respect to Health Canada’s Special Access Program, including the Company’s expectations with respect to exceeding any potential regulatory standards set by such program; statements with respect to further evaluation and testing of the Company’s naturally occurring psilocybe truffles by CCrest Laboratories for scientific and medical purposes; the potential of the Company’s products being used for scientific and medical purposes; the potential of the Company’s products being used for Health Canada’s Special Access Program; and the Company’s ability to establish itself as the leader in the recreational psychedelics sector.

Forward-looking information is based on a number of key expectations and assumptions made by Red Light Holland, including without limitation: the COVID-19 pandemic impact on the Canadian economy and Red Light Holland’s business, and the extent and duration of such impact; no change to laws or regulations that negatively affect Red Light Holland’s business; there will be a demand for Red Light Holland’s products in the future; no unanticipated expenses or costs arise; the Company will be able to continue to develop products that are allowed to be imported and sold under Health Canada’s import permit; and the partnership with Shaman Pharma Corp. will help Red Light Holland to achieve its business goals. Although the forward-looking information contained in this news release is based upon what the Company believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the inability of the Company to continue as a going concern; the inability of the Company to obtain all necessary governmental and/or other regulatory approvals, licenses, and permits necessary to operate and expand the Company’s facilities; the effect of regulatory and/or political change and its effect on the legislation and regulations surrounding the psychedelics industry including SAP; negative perception of the medical-use and adult-use psilocybin industry; the inability of CCrest to complete the planned testing of the Company’s products; the inability of the Company to create a standardized dose; the potential unviability of psilocybin for medical and/or scientific purposes; the inability for the company to use their psilocybin in any potential clinical use of naturally occurring Psilocybin; the inability for the Company to continue product development and research and development; the inability of the Company to continue its growth; the Company’s limited operating history; reliance on management; the Company’s requirements for additional financing; and competition for mental health and wellness investments.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Wiz Khalifa launches shroom brand

Red Light Holland and Superstar Wiz Khalifa to Launch Naturally Occurring Psilocybin and Mushrooms Wellness Brand: Mistercap

In partnership with Red Light Holland (TRIP), multi-platinum rapper Wiz Khalifa is starting a psychedelic and functional mushroom brand called MISTERCAP.

Red Light Holland hopes to leverage Khalifa’s huge following and entrepreneurial success in the cannabis industry to help end the stigma surrounding psilocybin.

The brand will sell:

  • Recreational psilocybin truffles in the Netherlands (potentially expanding to other markets if legalized)
  • Mushroom growing kits in the US, Canada, and Europe (launching by the end of this year)
  • Other functional mushroom products
  • And, of course, merch 

[ Insert reference to Young, Wild & Free ] 

Red Light Holland also announced that it’s starting a new program to provide advice and funding to business owners who are looking to enter Oregon’s legal psilocybin therapy market.

PDF of article 1

PDF of article 2

Posted on

Red Light Holland CCO Russell Peters Completes Psilocybin Truffles Journey in Amsterdam and Will Live Stream a Q&A Today (May 24th, 2022) at 2pm ET on Twitter @TheRealRussellP (3.9m Followers) and Multiple Red Light Social Media Accounts

Red Light Holland CCO Russell Peters Completes Psilocybin Truffles Journey in Amsterdam and Will Live Stream a Q&A Today (May 24th, 2022) at 2pm ET on Twitter @TheRealRussellP (3.9m Followers) and Multiple Red Light Social Media Accounts

  • CEO Todd Shapiro will interview Russell Peters later today, May 24th, at 8 PM CET / 2PM ET in front of an invite only audience about Russell’s candid journey with Red Light’s Therapist Jeff Hamburg
  • This unique candid Red Light Event will be live streamed on Russell Peters’ Twitter account (@TheRealRussellP – 3.9m) plus Todd Shapiro’s and Red Light Holland’s social media accounts May 24th 2 PM ET
  • The Live event will be held in a secret central location in a popular Amsterdam hotel with an exclusive VIP party after the Q&A

Toronto, Ontario–(Newsfile Corp. – May 24, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce Russell Peters, the company’s Chief Creative Officer, currently in Amsterdam, has completed his first psychedelic journey.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/2017/125102_5c58f74fe4e23862_001.jpg

Russell Peters and therapist Jeff Hamburg before the Psilocybin Journey

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/125102_5c58f74fe4e23862_001full.jpg

Russell carefully used Red Light Holland’s premium psilocybin truffles and was guided by Red Light Holland’s therapist and expert psychedelic guide Jeff Hamburg. Peters will have a special Q&A session in front of a live audience which will be live-streamed on Russell Peters’ Twitter account (@TheRealRussellP – 3.9m followers) plus Todd Shapiro’s and Red Light’s Holland’s social media accounts on May 24th (later today) now that Russell has completed his psychedelic journey.

The Q&A will be hosted by CEO Todd Shapiro and the event will air live on May 24th at 2 PM ET. The Q&A will be followed by an exclusive VIP party.

“We did it! I’m proud, I’m feeling great and I’m excited to share my journey to the world, later today, with my buddy Todd Shapiro,” said Red Light CCO Russell Peters.

“Russell joked with me that this was supposed to be his down time on his global comedy tour! I mean here’s a guy who just played in Dubai and most recently at Wembley Stadium in London – yet he made invaluable time for all of us at Red Light Holland,” said CEO and Director Todd Shapiro. “Please tune in to Russell Peters’ Twitter handle – @TheRealRussellP (3.9m followers) or my (@IAmToddyTickles) social media handles (approx 60k followers) or all Red Light Holland social media handles at 2pm ET for the Q&A! And if you miss the livestream don’t worry – like a podcast – this will continue to be online for as long as you want to watch or listen to it! Tell your friends and family as we are proud to have a bigger and broader conversation around ending the stigma around psychedelics with the continued hope of helping create positive change.”

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website:www.RedLight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the ability for Russell Peters and Todd Shapiro to host the live stream on May 24th in the Netherlands, the intimate live event featuring Russell Peters hosted by Todd Shapiro and the live-streaming of the event; the commencement and projected date regarding the Company’s ability to ensure the live event will happen on the Company’s social media accounts or on Russell Peters’ social media Twitter account (3.9m followers) or on Todd Shapiro’s social media accounts (approx 60k followers,) the venue for the event; statements about the future of the live session with Russell Peters and Todd Shapiro; that the company will have the live q&a at a secret, popular Amsterdam hotel.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com, including the Company’s annual information form for the year ended March 31, 2020.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland Successfully Imports 200 Psilocybin iMicrodose Packs, Sold in The Netherlands, Into Canada Under a Third Health Canada Approved Psilocybin Import Permit To cGMP Laboratory

Red Light Holland Successfully Imports 200 Psilocybin iMicrodose Packs, Sold in The Netherlands, Into Canada Under a Third Health Canada Approved Psilocybin Import Permit To cGMP Laboratory

  • Red Light Holland proudly exports a commercial sale of 3000 Grams (200 x 15g packs) of Psilocybin Truffles (Psilocybe Tampanensis) grown in the Company’s Farm in Horst, The Netherlands to its laboratory partner, CCrest Laboratories Inc., a cGMP pharmaceutical laboratory in Montreal, Canada
  • Red Light Holland has an established alliance with CCrest Laboratories Inc. in partnership with Shaman Pharma Corp., who have been listed by Health Canada as a Psilocybin supplier to the Special Access Program.
  • CCrest Laboratories will continue to perform stability tests and R&D towards creating a standardized consistent dose from naturally occurring psilocybin truffles.

Toronto, Ontario–(Newsfile Corp. – May 16, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of it’s Psilocybin magic truffles, is pleased to announce that it has completed the third export of the company’s freshly harvested high-grade psilocybe truffles, from the Netherlands to Canada, under a Health Canada psilocybin import permit awarded to CCrest Laboratories Inc. in partnership with Shaman Pharma Corp. CCrest Laboratories received 200 of Red Light Holland’s psilocybe truffles kits, a total of 3 kg (200 x 15g packs) of Psilocybin Truffles (Psilocybe Tampanensis) grown in the Company’s Farm in Horst, The Netherlands.

“I’m absolutely thrilled to have completed our third import and sale of our Psilocybin Truffles from the Netherlands to Canada to our partners CCrest Labs, who have been listed as a provider of Psilocybin for the Special Access Program by Health Canada,” said Todd Shapiro, CEO and Director of Red Light Holland. “We thought it was important to ship a large number of our actual iMicrodose packs to CCrest Labs this time, in case they could ever be used by patients through the Special Access Program. This is just another milestone for Red Light Holland and our loyal shareholders.”

“Our previous testing has shown that our truffles are suitable as a source of active pharmaceutical ingredients (“API”) for scientific and potentially medical and therapeutic purposes and we are excited to continue the testing and R&D with our partners at CCrest Labs,” said Sarah Haskes, CTIO of Red Light Holland. “We continue to move towards our goal of creating a standardized consistent dose from naturally occurring psilocybin truffles, which our market research shows people are interested in. This can potentially benefit both the recreational and medicinal markets and we continue our path to work within the careful means of the regulatory process with reliable partners in hopes of pushing for safe, responsible access to the company’s naturally occurring psilocybin by testing, learning and educating the public and hopefully Governments right here in Canada and across the world.”

CCrest Laboratories, a cGMP pharmaceutical laboratory in Montreal specializing in highly regulated narcotics, including psychedelics, holds a Health Canada Controlled Drugs and Substances License, and received federally issued import permits for the restricted drug Psilocybin. CCrest has also been listed as a provider of Psilocybin for the Special Access Program in Canada.

Shaman Pharma, working in conjunction with CCrest Laboratories, is developing cGMP compliant scientific methods and protocols of Quality Control, Analysis and Extraction, aimed at industrial-scale commercialization of medical purpose psychedelic substances in this emerging pharmaceutical sector. Together with Red Light Holland, the companies are setting the pace at which regulatory requirements are exceeded, opening a new realm of possibilities for disruptive healthcare innovation.

“This third shipment marks the continuation of the previously announced progress achieved between Red Light Holland and CCrest Labs,” commented Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories. “Notable points are that we have a 100% success rate while increasing quantities, it looks promising for a certain maturity and scale in a supply chain that had not been achieved until now. We set out to demonstrate beyond any doubt that patients, and responsible adults in general, should be able to reliably and safely access psilocybin from natural sources. While much research remains, so far there doesn’t seem to be any impurities or toxins present that would disqualify a natural source. Actually, to us it is rapidly becoming more interesting to study than pure (synthetic) psilocybin. Simply put, it’s a richer platform for discovery, and we would hate to miss out on something that nature has potentially perfected.”

Making larger quantities available to the scientists enables deepening the research into the composition of the raw materials – the scientific protocols are now expanded for the detection and quantification of other active ingredients known to exist alongside psilocybin and psilocin, mainly the compounds norpsilocin, baeocystin, norbaeocystin and aeruginascin. While expected to be present in very small quantities, they could prove to have large modulation effects. This could arguably establish a new realm of possibilities beyond simple dosage of psilocybin, where a near infinite number of combinations exist between the various compounds.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

About Shaman Pharma Corp.

Shaman Pharma is a federally registered Canadian corporation with the mission to power outstanding psychedelic life science innovation. Accelerating time-to-market through its portfolio of assets, Shaman launches and consolidates revenue-driven pharma-biotech life sciences ventures focused on supplying psychedelic drugs & novel active ingredients.

Forward-Looking Statements

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of Red Light Holland. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward looking statements include, but are not limited to: statements with respect to the evaluation and testing of the Company’s naturally occurring psilocybe truffles by CCrest Laboratories for scientific and medical purposes; the potential of the Company’s products being used for scientific and medical purposes; the potential of the Company’s products being used for Health Canada’s Special Access Program; the potential for Red Light Holland, CCrest Labs and Shaman Pharma to be disruptive in healthcare innovation; statements with respect to the Company’s expansion into the mental wellness pharmaceutical sector; the future sharing of the test results with the Company’s customers and shareholders; the future ability to create standardized dosages from naturally occurring products from psilocybin; and the Company’s ability to establish itself as the leader in the recreational psychedelics’ sector.

Forward-looking information is based on a number of key expectations and assumptions made by Red Light Holland, including without limitation: the COVID-19 pandemic impact on the Canadian economy and Red Light Holland’s business, and the extent and duration of such impact; no change to laws or regulations that negatively affect Red Light Holland’s business; there will be a demand for Red Light Holland’s products in the future; no unanticipated expenses or costs arise; the Company will be able to continue to develop products that are allowed to be imported and sold under Health Canada’s import permit; and the partnership with Shaman Pharma Corp. will help Red Light Holland to achieve its business goals. Although the forward-looking information contained in this news release is based upon what the Company believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the inability of the Company to continue as a going concern; the inability of the Company to obtain all necessary governmental and/or other regulatory approvals, licenses, and permits necessary to operate and expand the Company’s facilities; the effect of regulatory and/or political change and its effect on the legislation and regulations surrounding the psychedelics industry; the negative perception of the medical-use and adult-use psilocybin industry; the inability of CCrest to complete the planned testing of the Company’s products; the inability of CCrest labs and Red Light Holland to advance standardized doses of psilocybin; the potential unviability of psilocybin for medical and/or scientific purposes; the potential to ever have the Company’s Truffles approved for patients under Health Canada’s Special Access Program the inability of the Company to continue its growth; the Company’s limited operating history; reliance on management; the Company’s requirements for additional financing; and competition for mental health and wellness investments.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Red Light Holland Engages Akwasi Owusu-Bempah, Respected Academic, Author and Drug Law Reform and Drug Equity Expert, as Advisor to Advisory Board

Red Light Holland Engages Akwasi Owusu-Bempah, Respected Academic, Author and Drug Law Reform and Drug Equity Expert, as Advisor to Advisory Board

Toronto, Ontario–(Newsfile Corp. – May 11, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands is pleased to announce it has engaged Akwasi Owusu-Bempah to serve as an Advisor to its Advisory Board.

Akwasi Owusu-Bempah (PhD) is a respected Canadian academic and drug law reform expert. He brings extensive experience working across public and private sectors in Canada and internationally.

Akwasi’s academic work has examined the unequal nature of drug law enforcement across North America. He has collaborated with major media outlets to advance public dialogue about the perils of the war on drugs. As a change-maker, Akwasi has lobbied federal governments to revise their drug laws, and through his not-for-profit work, has collaborated with some of the world’s largest cannabis companies to advance their corporate responsibility mandates. He recently sat as a member of Health Canada’s Expert Task Force on Substance Use and has contributed to ongoing decriminalization efforts across the country.

“We are elated to have Akwasi join Red Light’s advisory board,” said Todd Shapiro, CEO and director of Red Light Holland. “When we connected I instantly knew he’d be a perfect fit. Akwasi and Red Light are fully aligned on our beliefs that psilocybin should be accessed on an affordable and equitable basis through education, information and responsible use. Akwasi is another wonderful asset to the Red Light team and we are grateful as we are confident his experience, knowledge and past lobbying efforts plus his educational pieces will help open the eyes and ears of health regulatory bodies across the world.”

“I am excited to work with Red Light Holland and its efforts to bring psilocybin from underground to mainstream,” added Akwasi Owusu-Bempah. “Todd and his team have shown great leadership in the psychedelics space and I look forward to contributing to the company’s social purpose and advocacy strategy as Red Light continues to expand and grow. I’m proud to bring my expertise and knowledge to help assist Red Light’s mission.”

In consideration for his services as Advisor, and subject to all applicable laws (including the rules and policies of the Canadian Securities Exchange) (“Applicable Laws”) the Company has granted to Mr. Owusu-Bempah 300,000 incentive stock options (the “Options” and each individually, the “Option”). Each Option will entitle the holder thereof to acquire one common share in the capital of Company for a period of three years from the date of issuance but can only be exercised half at a time after 1 and 2 years respectively, at an exercise price of $0.09 CND. The Options shall be subject to Applicable Laws and the terms and conditions of the Stock Option Plan of the Company.

Updated Investor Deck

The Company is also pleased to announce it has uploaded a new investor deck – Red Light’s Triangular Approach – to its company website www.redlight.co, offering an in-depth overview of the Company’s vision and its triangular approach to achieving such vision.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: Todd Shapiro’s statement with respect to Akwasi opening the eye and ear of health regulatory bodies across the world; and Akwasi’s statement with respect to Red Light continuing to expand and grow.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; continued demand for the Company’s products; the ability of Akwasi and Red Light to continue working together; and the ability of Akwasi to impact health regulatory bodies across the world.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland Engages Akwasi Owusu-Bempah, Respected Academic, Author and Drug Law Reform and Drug Equity Expert, as Advisor to Advisory Board

Red Light Holland Engages Akwasi Owusu-Bempah, Respected Academic, Author and Drug Law Reform and Drug Equity Expert, as Advisor to Advisory Board

Toronto, Ontario–(Newsfile Corp. – May 11, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands is pleased to announce it has engaged Akwasi Owusu-Bempah to serve as an Advisor to its Advisory Board.

Akwasi Owusu-Bempah (PhD) is a respected Canadian academic and drug law reform expert. He brings extensive experience working across public and private sectors in Canada and internationally.

Akwasi’s academic work has examined the unequal nature of drug law enforcement across North America. He has collaborated with major media outlets to advance public dialogue about the perils of the war on drugs. As a change-maker, Akwasi has lobbied federal governments to revise their drug laws, and through his not-for-profit work, has collaborated with some of the world’s largest cannabis companies to advance their corporate responsibility mandates. He recently sat as a member of Health Canada’s Expert Task Force on Substance Use and has contributed to ongoing decriminalization efforts across the country.

“We are elated to have Akwasi join Red Light’s advisory board,” said Todd Shapiro, CEO and director of Red Light Holland. “When we connected I instantly knew he’d be a perfect fit. Akwasi and Red Light are fully aligned on our beliefs that psilocybin should be accessed on an affordable and equitable basis through education, information and responsible use. Akwasi is another wonderful asset to the Red Light team and we are grateful as we are confident his experience, knowledge and past lobbying efforts plus his educational pieces will help open the eyes and ears of health regulatory bodies across the world.”

“I am excited to work with Red Light Holland and its efforts to bring psilocybin from underground to mainstream,” added Akwasi Owusu-Bempah. “Todd and his team have shown great leadership in the psychedelics space and I look forward to contributing to the company’s social purpose and advocacy strategy as Red Light continues to expand and grow. I’m proud to bring my expertise and knowledge to help assist Red Light’s mission.”

In consideration for his services as Advisor, and subject to all applicable laws (including the rules and policies of the Canadian Securities Exchange) (“Applicable Laws”) the Company has granted to Mr. Owusu-Bempah 300,000 incentive stock options (the “Options” and each individually, the “Option”). Each Option will entitle the holder thereof to acquire one common share in the capital of Company for a period of three years from the date of issuance but can only be exercised half at a time after 1 and 2 years respectively, at an exercise price of $0.09 CND. The Options shall be subject to Applicable Laws and the terms and conditions of the Stock Option Plan of the Company.

Updated Investor Deck

The Company is also pleased to announce it has uploaded a new investor deck – Red Light’s Triangular Approach – to its company website www.redlight.co, offering an in-depth overview of the Company’s vision and its triangular approach to achieving such vision.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: Todd Shapiro’s statement with respect to Akwasi opening the eye and ear of health regulatory bodies across the world; and Akwasi’s statement with respect to Red Light continuing to expand and grow.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; continued demand for the Company’s products; the ability of Akwasi and Red Light to continue working together; and the ability of Akwasi to impact health regulatory bodies across the world.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.